About Santarus
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. Learn More
Investor Information
Investor Information
News Releases
Products
GLUMETZA® (metformin hydrochloride extended release tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. As with all metformin products, GLUMETZA has a boxed warning for lactic acidosis. Please click here for Important Safety Information and Full Prescribing Information, including boxed warning.
CYCLOSET® (bromocriptine mesylate) is a first-in-class antidiabetic treatment that may lower your blood sugar, without increasing insulin.
FENOGLIDE® is a fenofibrate prescribed to treat adults with hyperlipidemia (high cholesterol in the blood), mixed dyslipidemia (a combination of high Low-density lipoprotein (LDL) cholesterol, high triglycerides, and low High-density lipoprotein (HDL) cholesterol), or hypertriglyceridemia (high triglyceride levels in the blood) in combination with eating a healthy diet low in saturated fat and cholesterol.
ZEGERID® (omeprazole/sodium bicarbonate) is an immediate-release oral proton pump inhibitor (PPI) used in adults for up to 4 weeks to treat heartburn and other symptoms that happen with gastroesophageal reflex disease (GERD).
Pipeline
Learn More Have Questions? Request Medical Information